These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 18500360)

  • 21. Brivaracetam for the treatment of epilepsy.
    Klein P; Tyrlikova I; Brazdil M; Rektor I
    Expert Opin Pharmacother; 2016; 17(2):283-95. PubMed ID: 26760311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models.
    Stafstrom CE; Ockuly JC; Murphree L; Valley MT; Roopra A; Sutula TP
    Ann Neurol; 2009 Apr; 65(4):435-47. PubMed ID: 19399874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brivaracetam Prevents the Over-expression of Synaptic Vesicle Protein 2A and Rescues the Deficits of Hippocampal Long-term Potentiation In Vivo in Chronic Temporal Lobe Epilepsy Rats.
    Ge YX; Lin YY; Bi QQ; Chen YJ
    Curr Neurovasc Res; 2020; 17(4):354-360. PubMed ID: 32407277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brivaracetam and seletracetam, two new SV2A ligands, improve paroxysmal dystonia in the dt sz mutant hamster.
    Hamann M; Sander SE; Richter A
    Eur J Pharmacol; 2008 Dec; 601(1-3):99-102. PubMed ID: 19014930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Omega 3 polyunsaturated fatty acids enhance the protective effect of levetiracetam against seizures, cognitive impairment and hippocampal oxidative DNA damage in young kindled rats.
    Abdel-Wahab BA; Shaikh IA; Khateeb MM; Habeeb SM
    Pharmacol Biochem Behav; 2015 Aug; 135():105-13. PubMed ID: 26044965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic Effects of Time-Limited Treatment with Brivaracetam on Posttraumatic Epilepsy after Fluid Percussion Injury in the Rat.
    Eastman CL; Fender JS; Klein P; D'Ambrosio R
    J Pharmacol Exp Ther; 2021 Dec; 379(3):310-323. PubMed ID: 34593559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABA
    Wood M; Daniels V; Provins L; Wolff C; Kaminski RM; Gillard M
    J Pharmacol Exp Ther; 2020 Jan; 372(1):1-10. PubMed ID: 31619465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy.
    Löscher W; Hönack D; Rundfeldt C
    J Pharmacol Exp Ther; 1998 Feb; 284(2):474-9. PubMed ID: 9454787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levetiracetam prevents kindling-induced asymmetric accumulation of hippocampal 7S SNARE complexes.
    Matveeva EA; Vanaman TC; Whiteheart SW; Slevin JT
    Epilepsia; 2008 Oct; 49(10):1749-58. PubMed ID: 18513349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticonvulsant profile of valrocemide (TV1901): a new antiepileptic drug.
    Isoherranen N; Woodhead JH; White HS; Bialer M
    Epilepsia; 2001 Jul; 42(7):831-6. PubMed ID: 11488880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model.
    Sanon NT; Gagné J; Wolf DC; Aboulamer S; Bosoi CM; Simard A; Messiet E; Desgent S; Carmant L
    Epilepsy Behav; 2018 Feb; 79():117-125. PubMed ID: 29287214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brivaracetam (UCB 34714).
    von Rosenstiel P
    Neurotherapeutics; 2007 Jan; 4(1):84-7. PubMed ID: 17199019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are neuronal nicotinic receptors a target for antiepileptic drug development? Studies in different seizure models in mice and rats.
    Löscher W; Potschka H; Wlaź P; Danysz W; Parsons CG
    Eur J Pharmacol; 2003 Apr; 466(1-2):99-111. PubMed ID: 12679146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.
    Lynch BA; Lambeng N; Nocka K; Kensel-Hammes P; Bajjalieh SM; Matagne A; Fuks B
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9861-6. PubMed ID: 15210974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticonvulsive and antiepileptogenic effects of levetiracetam in the audiogenic kindling model.
    Vinogradova LV; van Rijn CM
    Epilepsia; 2008 Jul; 49(7):1160-8. PubMed ID: 18397292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Examination of the antiepileptic effects of valacyclovir using kindling mice- search for novel antiepileptic agents by drug repositioning using a large medical information database.
    Takahashi S; Takechi K; Jozukuri N; Niimura T; Chuma M; Goda M; Zamami Y; Izawa-Ishizawa Y; Imanishi M; Horinouchi Y; Ikeda Y; Tsuchiya K; Yanagawa H; Ishizawa K
    Eur J Pharmacol; 2021 Jul; 902():174099. PubMed ID: 33910036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of lamotrigine and levetiracetam on seizure development in a rat amygdala kindling model.
    Stratton SC; Large CH; Cox B; Davies G; Hagan RM
    Epilepsy Res; 2003 Feb; 53(1-2):95-106. PubMed ID: 12576171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brivaracetam: First Global Approval.
    Markham A
    Drugs; 2016 Mar; 76(4):517-22. PubMed ID: 26899665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cortico-hippocampal hyperexcitability in synapsin I/II/III knockout mice: age-dependency and response to the antiepileptic drug levetiracetam.
    Boido D; Farisello P; Cesca F; Ferrea E; Valtorta F; Benfenati F; Baldelli P
    Neuroscience; 2010 Nov; 171(1):268-83. PubMed ID: 20804820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychopharmacology of anticonvulsants: levetiracetam as a synaptic vesicle protein modulator.
    Stahl SM
    J Clin Psychiatry; 2004 Sep; 65(9):1162-3. PubMed ID: 15367040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.